S, I., R, S., & S, H. (2026). 25-hydroxyvitamin D and the initial presentation of pediatric type 1 diabetes: Associations with ketoacidosis severity and beta-cell function. Frontiers in endocrinology, 17, 1814563. https://doi.org/10.3389/fendo.2026.1814563
Chicago Style (17th ed.) CitationS, Ilmer, Sohail R, and Hyman S. "25-hydroxyvitamin D and the Initial Presentation of Pediatric Type 1 Diabetes: Associations with Ketoacidosis Severity and Beta-cell Function." Frontiers in Endocrinology 17 (2026): 1814563. https://doi.org/10.3389/fendo.2026.1814563.
MLA (9th ed.) CitationS, Ilmer, et al. "25-hydroxyvitamin D and the Initial Presentation of Pediatric Type 1 Diabetes: Associations with Ketoacidosis Severity and Beta-cell Function." Frontiers in Endocrinology, vol. 17, 2026, p. 1814563, https://doi.org/10.3389/fendo.2026.1814563.